Efficacy of low-dose rituximab in minimal change disease and prevention of relapse

BACKGROUND: Minimal change disease (MCD) is a major cause of nephrotic syndrome (NS) in children and a minority of adults. The higher tendency to relapse put patients at risk for prolonged exposure to steroids and other immunosuppressive agents. B cell depletion with rituximab (RTX) may be beneficia...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Zhao, Hui, Li, Xiaoli, Qian, Rui, Gao, Peijuan, Lu, Shouyan, Ma, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134665/
https://www.ncbi.nlm.nih.gov/pubmed/37101300
http://dx.doi.org/10.1186/s12882-023-03092-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134665/
https://www.ncbi.nlm.nih.gov/pubmed/37101300
http://dx.doi.org/10.1186/s12882-023-03092-7

Ejemplares similares